SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-24-002559
Filing Date
2024-04-15
Accepted
2024-04-15 19:26:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11029026_13d-a.htm SC 13D/A 102667
  Complete submission text file 0000919574-24-002559.txt   104623
Mailing Address BROADWOOD CAPITAL INC. 142 WEST 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 142 WEST 57TH STREET, 11TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Filed by) CIK: 0001278386 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Subject) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89221 | Film No.: 24845836
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)